The Full Wiki

More info on 2-Ethoxymethyl Salvinorin B

2-Ethoxymethyl Salvinorin B: Wikis

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

2-Ethoxymethyl Salvinorin B
Systematic (IUPAC) name
(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(ethoxymethoxy)-2-(3-furanyl)dodecahydro -6a,10b-dimethyl-4,10-dioxo-2H-naphtho-[2,1-c]pyran-7-carboxylic acid methyl ester
CAS number  ?
ATC code none
PubChem 24873526
Chemical data
Formula C 24H32O8  
Mol. mass 448.505 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status Legal
Routes  ?

2-Ethoxymethyl Salvinorin B (Symmetry, 2-EtOMe-Sal B) is a semi-synthetic analogue of the natural product Salvinorin A, with a longer duration of action of around 3 hours (compared to less than 30 minutes for Salvinorin A), and increased affinity and efficacy at the κ-opioid receptor. Like the related compound herkinorin, 2-Ethoxymethyl Salvinorin B is made from Salvinorin B, which is most conveniently made from Salvinorin A by deacetylation,[1] as while both Salvinorin A and Salvinorin B are found in the plant Salvia divinorum, Salvinorin A is present in larger quantities.[2]

2-Ethoxymethyl Salvinorin B has a Ki of 0.32nM at the κ opioid receptor, and around 3000x selectivity over the μ and δ opioid receptors, making it one of the most potent and selective kappa agonists yet discovered.[3] In animal studies it fully substituted for Salvinorin A and the synthetic kappa agonist U-69593, and was active at doses as low as 0.005 mg/kg.[4] Human bioassays found the compound to be active at 50μg, but generally unpleasant in effects.[5]

See also


  1. ^ Lee DY, Karnati VV, He M, Liu-Chen LY, Kondaveti L, Ma Z, Wang Y, Chen Y, Beguin C, Carlezon WA, Cohen B (August 2005). "Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues". Bioorganic & Medicinal Chemistry Letters 15 (16): 3744–7. doi:10.1016/j.bmcl.2005.05.048. PMID 15993589.  
  2. ^ Medana C, Massolino C, Pazzi M, Baiocchi C (2006). "Determination of salvinorins and divinatorins in Salvia divinorum leaves by liquid chromatography/multistage mass spectrometry". Rapid Communications in Mass Spectrometry : RCM 20 (2): 131–6. doi:10.1002/rcm.2288. PMID 16331747.  
  3. ^ Munro TA, Duncan KK, Xu W, Wang Y, Liu-Chen LY, Carlezon WA, Cohen BM, Béguin C (February 2008). "Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers". Bioorganic & Medicinal Chemistry 16 (3): 1279–86. doi:10.1016/j.bmc.2007.10.067. PMID 17981041.  
  4. ^ Baker LE, Panos JJ, Killinger BA, Peet MM, Bell LM, Haliw LA, Walker SL (April 2009). "Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats". Psychopharmacology 203 (2): 203–11. doi:10.1007/s00213-008-1458-3. PMID 19153716.  
  5. ^ First Look at a New Psychoactive Drug:Symmetry (salvinorin B ethoxymethyl ether). The Entheogen Review. 2008;16(4):136-45.

Got something to say? Make a comment.
Your name
Your email address